Cargando…
Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England
BACKGROUND: The updated national guidelines for cardiovascular risk assessment and lipid modification in the UK and US expand the indications for statin therapy in primary prevention to adults with moderate risk of cardiovascular disease (CVD) but many adults at high CVD risk remain untreated in bot...
Autores principales: | Ueda, Peter, Lung, Thomas Wai-Chun, Lu, Yuan, Salomon, Joshua A., Rahimi, Kazem, Clarke, Philip, Danaei, Goodarz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862405/ https://www.ncbi.nlm.nih.gov/pubmed/29561843 http://dx.doi.org/10.1371/journal.pone.0190688 |
Ejemplares similares
-
Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
por: Saadati, Hassan, et al.
Publicado: (2020) -
Statins and Risk of Diabetes: An analysis of electronic medical records to evaluate possible bias due to differential survival
por: Danaei, Goodarz, et al.
Publicado: (2013) -
Long-term moderately elevated LDL-cholesterol and blood pressure and risk of coronary heart disease
por: Ueda, Peter, et al.
Publicado: (2018) -
Teenage smoking behaviour following a high-school smoking ban in Chile: interrupted time-series analysis
por: Feigl, Andrea B, et al.
Publicado: (2015) -
Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study
por: Wander, Pandora L, et al.
Publicado: (2022)